ATE551354T1 - Modifizierte bakteriocine und verwendungsverfahren dafür - Google Patents

Modifizierte bakteriocine und verwendungsverfahren dafür

Info

Publication number
ATE551354T1
ATE551354T1 AT07797461T AT07797461T ATE551354T1 AT E551354 T1 ATE551354 T1 AT E551354T1 AT 07797461 T AT07797461 T AT 07797461T AT 07797461 T AT07797461 T AT 07797461T AT E551354 T1 ATE551354 T1 AT E551354T1
Authority
AT
Austria
Prior art keywords
bacteriocins
modified
methods
bacteria
receptors
Prior art date
Application number
AT07797461T
Other languages
English (en)
Inventor
David Martin
Andrew Jamieson
Dean Scholl
Steven Williams
Original Assignee
Avidbiotics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidbiotics Corp filed Critical Avidbiotics Corp
Application granted granted Critical
Publication of ATE551354T1 publication Critical patent/ATE551354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
AT07797461T 2006-05-15 2007-05-14 Modifizierte bakteriocine und verwendungsverfahren dafür ATE551354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74729906P 2006-05-15 2006-05-15
PCT/US2007/068908 WO2007134303A2 (en) 2006-05-15 2007-05-14 Modified bacteriocins and methods for their use

Publications (1)

Publication Number Publication Date
ATE551354T1 true ATE551354T1 (de) 2012-04-15

Family

ID=38694773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07797461T ATE551354T1 (de) 2006-05-15 2007-05-14 Modifizierte bakteriocine und verwendungsverfahren dafür

Country Status (11)

Country Link
US (1) US7732586B2 (de)
EP (2) EP2021358B1 (de)
JP (1) JP5603070B2 (de)
AT (1) ATE551354T1 (de)
AU (1) AU2007249199B2 (de)
BR (1) BRPI0711969A2 (de)
CA (1) CA2652450C (de)
DK (2) DK2021358T3 (de)
ES (2) ES2387722T3 (de)
PL (1) PL2021358T3 (de)
WO (1) WO2007134303A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007049770A1 (ja) * 2005-10-28 2009-04-30 明治製菓株式会社 緑膿菌の外膜タンパク質ｐａ５１５８
US8445639B2 (en) 2006-05-15 2013-05-21 Avidbiotics Corporation Recombinant bacteriophage and methods for their use
US8680019B2 (en) * 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US20090176654A1 (en) * 2007-08-10 2009-07-09 Protelix, Inc. Universal fibronectin type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
WO2009055697A1 (en) * 2007-10-24 2009-04-30 The Texas A & M University System Chimeric phage tail proteins and uses thereof
CA2800511C (en) * 2010-05-27 2022-03-01 Avidbiotics Corp. Diffocins and methods of use thereof
US9115354B2 (en) 2010-05-27 2015-08-25 Avidbiotics Corp. Diffocins and methods of use thereof
WO2011152899A1 (en) 2010-06-02 2011-12-08 Johns Hopkins University System and methods for determining drug resistance in microorganisms
WO2015022306A1 (en) 2013-08-12 2015-02-19 Dupont Nutrition Biosciences Aps Methods for classification of microorganisms from food products
GB201416788D0 (en) * 2014-09-23 2014-11-05 Univ Glasgow Therapeutic applications for pyocins
ES2788980T3 (es) * 2014-11-07 2020-10-23 Pylum Biosciences Inc Monocinas y métodos de uso
CA3069690A1 (en) 2017-07-12 2019-01-17 DDP Specialty Electronic Materials US, Inc. Compositions and methods for remediation of sulfate reducing prokaryotes
US11572595B2 (en) 2018-12-31 2023-02-07 Roche Molecular Systems, Inc. Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems
CN110129279B (zh) * 2019-04-24 2022-02-18 昆明理工大学 一种粪肠球菌噬菌体及其分离、纯化、富集和应用
KR20230013025A (ko) * 2020-04-07 2023-01-26 필럼 바이오사이언시스 인코포레이티드 엔테로신 및 이를 사용하는 방법
CN112083253B (zh) * 2020-09-18 2021-07-02 西南交通大学 一种直流下土壤电参量状态反演方法
WO2023178352A2 (en) * 2022-03-18 2023-09-21 Carnegie Mellon University Lysin and gp38 peptides for bacteria detection
EP4621049A1 (de) * 2024-03-19 2025-09-24 Invitris GmbH Multispezifische partikel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4142939A (en) * 1976-03-31 1979-03-06 Oregon State Board Of Higher Education, An Agency Of The State Of Oregon Method of producing an r-type bacteriocin and its use in the detection of specific microorganisms
US4861754A (en) * 1986-05-28 1989-08-29 Farkas Himsley Hannah Bacteriocins and compositions thereof in anti-viral treatment
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
CA2310561A1 (en) * 1997-11-25 1999-06-03 The General Hospital Corporation Virulence-associated nucleic acid sequences and uses thereof
US6818418B1 (en) * 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
WO2000060070A1 (en) 1999-04-01 2000-10-12 Innogenetics N.V. A polypeptide structure for use as a scaffold
EP1196041B1 (de) * 1999-07-06 2012-09-12 Friesland Brands B.V. Verfahren und mittel zur herstellung von verbesserten molkereiprodukten
US7034113B2 (en) * 2002-02-22 2006-04-25 Paradigm Diagnostics, Llc Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
EP1677834B1 (de) 2003-10-06 2014-01-08 Gangagen, Inc. Therapeutischer phage mit definierter dosis
WO2006015370A2 (en) * 2004-08-03 2006-02-09 The Regents Of The University Of California Site specific system for generating diversity protein sequences
US20060229244A1 (en) * 2004-09-27 2006-10-12 Robert Dorit Engineered bacteriocins and bacteriocin combinations and methods for treating bacterial based infections

Also Published As

Publication number Publication date
EP2371842B1 (de) 2015-07-22
JP2009537146A (ja) 2009-10-29
EP2021358B1 (de) 2012-03-28
US7732586B2 (en) 2010-06-08
EP2021358A2 (de) 2009-02-11
PL2021358T3 (pl) 2012-09-28
CA2652450A1 (en) 2007-11-22
WO2007134303A3 (en) 2008-03-13
AU2007249199B2 (en) 2012-02-09
AU2007249199A1 (en) 2007-11-22
CA2652450C (en) 2013-10-15
EP2371842A1 (de) 2011-10-05
DK2371842T3 (en) 2015-10-26
JP5603070B2 (ja) 2014-10-08
WO2007134303A2 (en) 2007-11-22
BRPI0711969A2 (pt) 2012-01-24
DK2021358T3 (da) 2012-07-16
ES2548392T3 (es) 2015-10-16
US20080113406A1 (en) 2008-05-15
ES2387722T3 (es) 2012-09-28

Similar Documents

Publication Publication Date Title
PL2021358T3 (pl) Modyfikowane bakteriocyny i sposoby ich stosowania
CY2025024I1 (el) Βελτιωμενα επιλεκτικα πρωτοϊνιδιων αντισωματα και η χρηση αυτων
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
JO2913B1 (en) Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
WO2006085938A3 (en) Il-13 binding agents
EP1809326A4 (de) Modulation von antikörperspezifität mittels anpassung der affinität zu verwandten antigenen
DK1868645T3 (da) Multivalent pneumokok-sakkarid-protein-konjugat-sammensætning
EP1896073A4 (de) Anti-il-23-antikörper, zusammensetzungen, verfahren und verwendung
WO2011039510A8 (en) Agents, uses and methods
DK1966130T3 (da) Modificerede lysin-mimetiske forbindelser
DK2061814T3 (da) Antistoffer og immunokonjugater og anvendelse deraf.
HUE044756T2 (hu) HER-3 elleni antitestek és alkalmazásuk
SMT202000607T1 (it) Proteine leganti l'interleuchina-13
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
BR112013011193A2 (pt) bacteriófago p4 recombinante e métodos para seu uso
JP2009521520A5 (de)
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
ATE445325T1 (de) Ölsuspensionskonzentrat
BRPI0617479A2 (pt) método e composição útil para manter ou melhorar a saúde gastrintestiinal de um animal, kit, meio para comunicação de informações ou instruções, e, uso de uma composição
BRPI0309513A2 (pt) composição para tratamento de fibras com efeito durável
CY1111652T1 (el) Αντιμικροβiακη συνθεση
WO2007030761A3 (en) Acyclic 1,4-diamines and uses thereof
JP2008542528A5 (de)
EP1934318A4 (de) Traktionsfluidzusammensetzung